On Apr. 2, 2018, Erez Israeli joined Indian pharmaceutical company Dr. Reddy’s as COO and global head of Generics & PSAI. Israeli, former president & CEO of Enzymotec, succeeded Abhijit Mukherjee, who retired on Mar. 31, 2018, after 15 years with the company. In his Israely, he will report to Dr. Reddy’s co-chairman & CEO, G.V. Prasad.

Before joining Enzymotec, Israeli worked for 23 years at Teva Pharmaceuticals where he has held several leadership position.

G.V. Prasad commented on the transition: “I would like to thank Abhijit for his valuable contribution to our company’s growth journey over the past fifteen years. I extend a warm welcome to Erez Israeli. Erez is an accomplished leader with a proven track record of achievement. His knowledge and experience from leading pharmaceutical businesses of scale will be valuable for our future growth.”